About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Type 1 Diabetes Extension Study | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT02734277

Type 1 Diabetes Extension Study

This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodula...

Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID)•12 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

Immune Tolerance Network (ITN)

Depending upon a participant's level of insulin production, participation may be as short as one return visit or a maximum of five years. Evaluation visits will include: * Overall health assessments * Blood and urine collections * Mixed meal tolerance test (MMTTs) for certain participants, per protocol.

Age

8 - 35 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Prior participant in an Immune Tolerance Network (ITN) executive committee approved T1DM study.
•Ability to sign informed consent/assent (as applicable for children).

Exclusion Criteria

•Any medical condition that in the opinion of the principal investigator would interfere with safe completion of the trial; or
•Inability to comply with the study visit schedule and required assessments.

Related studies

RECRUITINGPhase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321 · Type 1 Diabetes Mellitus

RECRUITINGPhase 2

An Adaptive Design Study of MTX228

NCT06474598 · Type 1 Diabetes Mellitus

Capillary OGTT Study

NCT06815081 · Type 1 Diabetes (T1D), Type 2 Diabetes

Feasibility of a Tailored Online Self-compassion Intervention

NCT07051005 · Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus (T2DM)

Characterization of Type 1 Diabetes Subgroup: An Artificial Intelligence Analysis of Clinical and Glucometric Features

NCT07461805 · Type 1 Diabetes Mellitus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 10, 2026Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment111

Start dateAug 2016

Last updatedMar 10, 2026

Condition

Type 1 Diabetes Mellitus T1DM T1D

Locations shown

UCSF School of Medicine

San Francisco, California

Stanford University

Stanford, California

University of Colorado School of Medicine: Barbara Davis Center for Diabetes

Aurora, Colorado

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 10, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions